JPS55147247A - Therapeutically active salicylamide esters* their manufacture and related pharmaceutical composition - Google Patents

Therapeutically active salicylamide esters* their manufacture and related pharmaceutical composition

Info

Publication number
JPS55147247A
JPS55147247A JP3764880A JP3764880A JPS55147247A JP S55147247 A JPS55147247 A JP S55147247A JP 3764880 A JP3764880 A JP 3764880A JP 3764880 A JP3764880 A JP 3764880A JP S55147247 A JPS55147247 A JP S55147247A
Authority
JP
Japan
Prior art keywords
salicylamide
esters
manufacture
pharmaceutical composition
therapeutically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3764880A
Other languages
English (en)
Japanese (ja)
Inventor
Reinaa Aruberuto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neopharmed SpA
Original Assignee
Neopharmed SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neopharmed SpA filed Critical Neopharmed SpA
Publication of JPS55147247A publication Critical patent/JPS55147247A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP3764880A 1979-03-27 1980-03-26 Therapeutically active salicylamide esters* their manufacture and related pharmaceutical composition Pending JPS55147247A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21320/79A IT1113331B (it) 1979-03-27 1979-03-27 Esteri della salicilammide con attivita' terapeutica,procedimento per la loro preparazione e relative composizioni farmaceutiche

Publications (1)

Publication Number Publication Date
JPS55147247A true JPS55147247A (en) 1980-11-17

Family

ID=11180059

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3764880A Pending JPS55147247A (en) 1979-03-27 1980-03-26 Therapeutically active salicylamide esters* their manufacture and related pharmaceutical composition

Country Status (12)

Country Link
US (1) US4268685A (it)
EP (1) EP0016460B1 (it)
JP (1) JPS55147247A (it)
AR (1) AR226555A1 (it)
AT (1) ATE1381T1 (it)
BE (1) BE882480A (it)
CA (1) CA1134366A (it)
DE (1) DE3060690D1 (it)
ES (1) ES489518A0 (it)
FR (1) FR2452479A1 (it)
IT (1) IT1113331B (it)
ZA (1) ZA801598B (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101928227A (zh) * 2009-12-16 2010-12-29 天津工业大学 6-甲氧基-2-萘乙酸与水杨酰苯胺类化合物的互联体前药制备方法及应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52102244A (en) * 1976-02-20 1977-08-27 Beecham Group Ltd Lenitive * antiipyretic and antiiinflamatory composition

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313848A (en) * 1964-06-18 1967-04-11 Parke Davis & Co Anthranilic acids and derivatives
IT1061780B (it) * 1966-09-03 1983-04-30 Italfarmaco Spa Acido n 4 carbossifenil antrantiico suoi derivati e processo per la loro preparazione
GB1187259A (en) * 1967-10-23 1970-04-08 Hexachimie New Aminoalkyl Esters of 2-Anilino-Nicotinic Acids and process for their manufacture
US3673243A (en) * 1968-05-08 1972-06-27 Sumitomo Chemical Co Novel process for producing o-anilinophenylaliphatic acid derivatives
FR1601574A (en) * 1968-12-02 1970-08-31 Anthraniloylsalicylic acids
US3657430A (en) * 1969-06-25 1972-04-18 Merck & Co Inc Composition and methods for treating inflammation
US3652762A (en) * 1970-04-14 1972-03-28 Ciba Geigy Corp Pharmaceutical compositions and methods employing substituted derivatives of 2-anilinophenylacetic acids and esters
JPS4725336U (it) * 1971-04-14 1972-11-21
JPS4930340A (it) * 1972-07-12 1974-03-18
US3778470A (en) * 1972-08-23 1973-12-11 A Sallman Chemical intermediates for the production of substituted 2-anilinophenylacetic acids and esters
US4029815A (en) * 1975-04-30 1977-06-14 Schering Corporation Anti-diarrheal anthranilic acids
JPS5220467A (en) * 1975-08-11 1977-02-16 Osaka Gas Co Ltd Device for preventing cooling crushed substance from showing crystalli ne exposure
US4150137A (en) * 1975-12-24 1979-04-17 Hisamitsu Pharmaceutical Co. Inc. Pyridylalkyl esters of 2-(p-isobutylphenyl)acetic acid and propionic acids and use
US4049700A (en) * 1976-06-17 1977-09-20 The Upjohn Company Ibuprofen p-hydroxyphenylurea ester
US4049699A (en) * 1976-06-17 1977-09-20 The Upjohn Company Ibuprofen p-hydroxybenzaldehyde semicarbazone ester
JPS53105445A (en) * 1977-02-26 1978-09-13 Hokuriku Pharmaceutical Nn*33trifluoromethylphenyl* anthranylate alklyester derivative and process for preparing same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52102244A (en) * 1976-02-20 1977-08-27 Beecham Group Ltd Lenitive * antiipyretic and antiiinflamatory composition

Also Published As

Publication number Publication date
US4268685A (en) 1981-05-19
EP0016460A1 (en) 1980-10-01
FR2452479A1 (fr) 1980-10-24
CA1134366A (en) 1982-10-26
FR2452479B1 (it) 1982-12-31
DE3060690D1 (en) 1982-09-16
EP0016460B1 (en) 1982-07-28
IT7921320A0 (it) 1979-03-27
BE882480A (fr) 1980-07-16
ES8102549A1 (es) 1981-02-16
AR226555A1 (es) 1982-07-30
IT1113331B (it) 1986-01-20
ZA801598B (en) 1980-10-29
ATE1381T1 (de) 1982-08-15
ES489518A0 (es) 1981-02-16

Similar Documents

Publication Publication Date Title
IL59628A (en) 4-amino-3-quinolinecarboxylic acids and salts and esters thereof and pharmaceutical compositions containing them
GB2103591B (en) Pharmaceutical compositions and process
IL51519A0 (en) Novel androstadiene-17-carboxylic acid esters their manufacture and pharmaceutical compositions containing them
IL61136A (en) Pharmaceutical and cosmetic compositions comprising nitric acid and their preparation
GB2066072B (en) Pharmaceutical compositions containing corticosteroids and arginine esters
GB2054588B (en) Amino-ether oxides and pharmaceutical formulations thereof
JPS55154943A (en) 22phenyllalkk11enyllcyclopropaneecarboxylic acid ester* its manufacture* use as insecticide and tickicide and intermediate for production
JPS55100313A (en) Drug composition and its manufacture
NZ194584A (en) -lactam antibiotics and pharmaceutical compositions
PH17548A (en) Pharmacologically active substituted-3-amino-sydnone-imines and process for their preparation
JPS55111494A (en) Monophosphonate compound* its manufacture and therapeutic composition containing same as active ingredient
NZ190842A (en) 4-substituted-thiazole-2-oxamic acids and esters and pharmaceutical compositions
JPS5663946A (en) Phenylethylamine derivative* its manufacture and medicinal composition containing it as active component
JPS562960A (en) Pyrrolidinylalkylcarboxylic acid amide derivative* its manufacture and medicinal composition
GB2065135B (en) Pharmacologically active peptides their preparation and pharmaceutical compositions containing them
GB2065133B (en) Pharmacologically active peptides their preparation and pharmaceutical compositions containing them
GB2065132B (en) Pharmacologically active peptides their preparation and pharmaceutical compositions containing them
NZ194784A (en) 7 -aminothiadizolylacetylamino-3-cephem-4-carboxylic acid derivatives and pharmaceutical compositions
GB2065134B (en) Pharmacologically active peptides their preparation and pharmaceutical compositions containing them
PT71066A (en) Process for the preparation of a pharmaceutical composition having analgesic and myotonolytical activity
IL60700A0 (en) 25-halocholest-5-ene-2 ,22-diols and esters thereof and pharmaceutical compositions containing them
JPS567750A (en) Oxyiminoosubstituteddcyclopropanecarboxylate esters* their manufacture* agricultural composition containing them and use as agricultural drug
JPS55147247A (en) Therapeutically active salicylamide esters* their manufacture and related pharmaceutical composition
JPS5692843A (en) Nnsubstituted alphaaamino acids*their manufacture and medicinal composition containing them
IL51472A0 (en) Pharmaceutical compositions comprising the salicylamide ester of aspirin and their preparation